Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,747 total articles
Innospec is trading near its 52-week low even as core fundamentals stay intact: market cap ~$1.7B, EV/EBITDA 6.48, FCF $88M and a P/E of ~14.6. The stock is deeply oversold (RSI ~20) and short interest has been elevated but manageable. If upstream activity reaccelerates, the Oilfield Services segment should provide a visible earnings lift and re-ra…
Sanmina's recent pullback priced in a worst-case scenario after conservative guidance, but the acquisition of ZT Systems and an ongoing preferred-partner arrangement with AMD materially change the revenue runway. The company generates meaningful free cash flow and trades at reasonable enterprise multiples given the growth opportunity in cloud AI in…
Fiserv has been punished — its stock trades near 52-week lows and at single-digit multiples despite $4.3B of free cash flow and positive operating returns. With a new CEO executing 'One Fiserv', recent beats, and cheap EV/EBITDA, this is a long-leaning trade that looks for multiple expansion as execution stabilizes.
Berkshire Hathaway trades like a mature conglomerate priced for inertia while sitting on a record cash hoard and generating steady free cash flow. With a market cap near $1.06 trillion, a P/E of about 15.7 and a P/B near 1.5, the stock looks attractively valued for investors willing to back new management and patient capital deployment. This trade …
Spotify's latest quarters show durable user momentum (MAUs ~751M, premium subscribers ~290M) and successful price increases that are already feeding margin expansion. The stock trades at $516.22 with a $106.3B market cap; our trade targets $750 over the next 180 trading days with a disciplined stop at $470 to protect against valuation-driven pullba…
Covista (CVSA) is a mid-cap education provider with a heavy nursing and healthcare tilt. Enrollment tailwinds from the nationwide shortage of nurses and allied health professionals are under-appreciated, and the stock trades at a reasonable multiple while technicals and a crowded short position add asymmetric upside. This trade idea lays out an act…
Solid Power (SLDP) looks buyable around current levels after a pullback into oversold territory and improving short-term momentum. The company still trades at a premium relative to revenue and is burning cash, so this is a tactical, conviction-weighted long with clearly defined risk controls: entry $3.20, stop $2.60, target $5.00 for a mid-term pla…
Pfizer is trading at a depressed multiple and a 6%+ yield despite stable cash generation, a manageable balance sheet and an improving pipeline. This trade idea recommends buying Pfizer at current levels to capture the dividend while positioning for a recovery in earnings and sentiment. Entry, stop and target provided with risk context and catalysts…
Signet (SIG) trades at an attractive multiple relative to its cash generation and carries multiple near-term catalysts: persistent jewelry spending (Valentine's strength), rising lab-grown adoption, and margin tailwinds from product mix and cost actions. With EV/EBITDA ~4.8 and P/FCF ~5.7 versus a $3.34B market cap, there's tangible upside if comps…
Capricor Therapeutics (CAPR) has a renewed regulatory runway for its lead cell therapy deramiocel. With a new PDUFA timeline in play, a compact float (~48.8M) and vigorous trading, we see an asymmetric risk/reward for disciplined long entries. This is a high-risk, high-reward position intended for investors who accept regulatory binary outcomes and…
Heineken shares look attractively priced after recent demand concerns. The company’s premium portfolio and exposure to emerging markets offer upside as macro volatility eases. We recommend a structured long with tight risk controls and clear catalysts to watch.
Deutsche Bank (DB) has fallen back from its January highs into a clear value setup: P/B ~0.73 and P/E ~7.4, a yield near 2.5%, and an RSI below 24. Technical momentum is negative, but the pullback has created an asymmetric risk/reward for a disciplined swing trade. Entry $29.10, stop $28.50, target $35.00 — primary holding horizon 45 trading days.
Halliburton is well positioned to outpace the market if sustained crude strength forces producers to accelerate budgeting and completion work. We upgrade to a buy and present a trade plan sized for tactical exposure: entry $45.00, stop $40.00, primary target $55.00 and an extended target $68.00 over a 180-trading-day horizon.
Moody's (MCO) is a high-margin, oligopolistic franchise trading below recent moving averages and closer to its 52-week low. With return on equity north of 60%, free cash flow of $2.575B and a market cap around $76B, the stock offers a favorable mid-term swing setup. This trade targets a rebound to $485 over the next 45 trading days while limiting d…
Airline fuel spikes make headlines, but Grupo Aeroportuario del Centro Norte's (OMA) cash flows and tariff framework make it resilient. This trade idea outlines a clear entry, stop and target with a 180-trading-day horizon, explains the fundamental drivers, and lays out catalysts and risks to monitor.
Arista Networks is benefitting from accelerated AI and cloud networking spending, strong Q4 results, and raised guidance. Fundamentals and technicals line up for a breakout toward consensus analyst targets. We upgrade to a tactical long with a clear entry at $133.00, a stop at $120.00 and a primary target at $177.50 over the next 45 trading days.
Village Super Market (VLGEA) screens inexpensive on multiple valuation metrics, produces meaningful free cash flow, and pays a steady quarterly dividend. Technical momentum and a compact float create a lens for a mid-term long trade. This idea lays out entry, stop, target and why the discount deserves attention, plus the risks that could derail the…
Ascent Industries (ACNT) is trading near $12.80 after a run of operational misses and heavy selling. The balance sheet is unusually strong for a small specialty-chemicals name - low debt, meaningful cash per share and an enterprise value well below market cap - and technical indicators are deeply oversold. This trade idea targets a mean-reversion b…
We upgrade Emergent BioSolutions (EBS) to Buy on attractive valuation, FCF generation and recent product & strategic wins. Technical oversold conditions and elevated short interest suggest continued volatility; we prefer to pick a precise entry at $7.50 while targeting $12.00 over a 180 trading-day horizon and using a $6.75 stop.
Nvidia remains the dominant supplier for AI compute. Market chatter around a customer called 'Nebius' suggests a new infrastructure deployment that could tilt near-term demand expectations—if real. Balance strong fundamentals - $4.45T market cap, $96.7B free cash flow, ROE 76% - against a premium multiple and mixed technical momentum. Trade idea: e…
GlobalFoundries priced a 20 million-share secondary at $42 by Mubadala with a concurrent $300 million buyback by the company. The deal reduces a headline dilution risk while expanding tradable float. Fundamentals remain intact: market cap ~$23.1B, PE ~26, and a deepening auto/industrial customer base. Technicals show the stock a touch weak below ke…
Zoetis (ZTS) is a dominant animal-health company trading at $114.81, near its 52-week low of $114.61. The business generates strong free cash flow ($2.283B) and earns high returns on equity (80%+), while valuation has compressed to roughly 18x trailing EPS. Technicals show oversold conditions and growing short interest. This trade idea outlines a m…
Triple Flag Precious Metals (TFPM) looks attractively priced for exposure to rising gold: market cap near $7.4B, a 52-week low of $17.72 but recent strength to $41.70 shows volatility and optionality. Current weakness offers a mid-term entry with defined risk and upside to the prior highs if gold continues its rally.
Sensible Meats (SSMTF) is an OTC-listed, early-stage cultured-meat company. FY25 margin erosion has pressured the story, but the core thesis - improving unit economics as production scales and regulatory progress unlocks commercialization - remains viable for patient, size-constrained speculators. This is a high-risk, asymmetric trade: small positi…
Boeing shares are trading near $207 after headlines about a new 737 MAX problem. The company still shows strong delivery performance, but an elevated valuation (P/E ~82-85, P/B ~29.5) combined with negative free cash flow and a high debt-to-equity ratio makes the stock vulnerable to an earnings or delivery disappointment. This trade idea outlines a…
